SCHEMBL6770575

SCHEMBL6770575

COc1cccc(-n2nc(C3CC3)c3c2CC(C(C)C)CC3=O)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPBAR1 Q8TDU6 4/20 0.39
▸ MAPT P10636 3/20 0.39
▸ KMT2A Q03164 2/20 0.38
▸ MGLL Q99685 1/20 0.38
▸ DHODH Q02127 1/20 0.38
▸ NSD2 O96028 1/20 0.37
▸ NSD1 Q96L73 1/20 0.37
▸ NSD3 Q9BZ95 1/20 0.37
▸ LPAR5 Q9H1C0 1/20 0.37
▸ HPSE Q9Y251 1/20 0.37
▸ RAB9A P51151 2/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ CASP1 P29466 1/20 0.36
▸ CASP7 P55210 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ SRC P12931 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6770505 0.88 OPRM1 (0.46) MAPTKMT2AMGLLDHODHRAB9A
SCHEMBL6770751 0.87 OPRM1 (0.45) KMT2ADHODHSMN1; SMN2MEN1SRC
SCHEMBL6777339 0.86 CASP1 (0.39) MAPTKMT2AMGLLDHODHRAB9A
SCHEMBL6772323 0.86 GPBAR1 (0.41) GPBAR1MAPTKMT2AMGLLNSD2
SCHEMBL6168419 0.85 DHODH (0.42) KMT2ADHODHSMN1; SMN2MEN1OPRM1
SCHEMBL6766674 0.84 RIPK2 (0.46) MAPTKMT2AMGLLDHODHRAB9A
SCHEMBL6772551 0.83 DHODH (0.37) MAPTKMT2AMGLLDHODHRAB9A
SCHEMBL6766574 0.82 ALDH1A1 (0.39) MAPTKMT2AMGLLDHODHRAB9A
SCHEMBL6772956 0.80 SRC (0.49) GPBAR1MAPTKMT2ANSD2NSD1
SCHEMBL6769850 0.79 OPRM1 (0.38) MAPTKMT2AMGLLDHODHSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6716856-B1 CELL PROLIFERATIVE DISORDERS OR ALZHEIMER'S DISEASE; REDUCED TOXICITY; CDK/CYCLIN KINASE INHIBITORY ACTIVITY PHARMACIA & TUBJOHN SPA (IT) 2004-04-06 — — US disclosed
EP-1177185-A1 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA & UPJOHN S.p.A. (IT) 2002-02-06 — — EP disclosed
WO-2000069846-A1 4,5,6,7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA & UPJOHN S.P.A. (IT) 2000-11-23 — — WO disclosed
Send feedback